Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography

NCT00209417 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

656

Enrollment

INDUSTRY

Sponsor class

Stopped Supported by preliminary interim analysis. Not based on any safety signals in study or any quality issues that could affect efficacy of the product.

Conditions

Renal Insufficiency
Diabetes Mellitus

Interventions

DRUG: Iodixanol 320-Arm 1
DRUG: Iopamidol 300-Arm 2

Sponsor

GE Healthcare

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]